2-n-propylquinoline has been researched along with betadex in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balaraman, K; Bories, C; Cojean, S; Figadère, B; Kesavan, V; Loiseau, PM; Moussa, F; Pomel, S; Vacus, J; Vieira, NC | 1 |
1 other study(ies) available for 2-n-propylquinoline and betadex
Article | Year |
---|---|
In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; Antiprotozoal Agents; beta-Cyclodextrins; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Female; Half-Life; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis, Visceral; Male; Mice; Mice, Inbred BALB C; Quinolines; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2015 |